Purpose : To compare the suppressive effects in hepatocellular carcinoma patients of transhepatic arterialchemoembolization by the infusion of adriamycin-lipiodol emulsion and of this plus 10ml of cisplatin solution.Materials and Methods : In a total of 151 cases, the frequency of intrahepatic recurrence was compared withfollow-up angiographic findings after the first and second transhepatic arterial chemoembolization withadriamycin-lipiodol emulsion and adriamycin-lipiodol emulsion plus 10ml of cisplatin solution, respectively.Results : Among 46 patients whose first single infusion was after mean 119 days, the recurrence rate was 22% ; for42 who were given their first multiple infusion after mean 76 days this rate was 5% ; for 35 whose second singleinfusion was administered after mean 147 days, the rate was 34%, and among 28 whose second multiple infusion wasafter mean 110 days, the rate was 43%. Conclusion : During the first trial of transcatheter arterialchemoembolization with adriamycin-lipiodol plus cisplatin solution, hepatocellular carcinoma recurred much lessfrequently, but during the second trial with cisplatin, recurrence was not suppresed.